- Report
- December 2024
- 150 Pages
Global
From €2819EUR$3,160USD£2,423GBP
€3523EUR$3,950USD£3,029GBP
- Report
- August 2025
- 145 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- November 2023
- 148 Pages
Global
From €3970EUR$4,450USD£3,413GBP
- Report
- August 2025
- 143 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- January 2025
- 144 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- December 2024
- 145 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- August 2022
- 140 Pages
Global
From €3791EUR$4,250USD£3,259GBP
- Report
- August 2025
- 149 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- January 2025
- 145 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- May 2024
- 124 Pages
Global
From €3523EUR$3,950USD£3,029GBP
- Report
- January 2024
- 143 Pages
Global
From €3791EUR$4,250USD£3,259GBP
- Report
- June 2023
- 113 Pages
Global
From €3970EUR$4,450USD£3,413GBP
- Report
- December 2022
- 142 Pages
Global
From €3970EUR$4,450USD£3,413GBP
- Report
- March 2026
- 153 Pages
Canada
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 162 Pages
China
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 154 Pages
Germany
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 155 Pages
India
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 150 Pages
Canada
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 184 Pages
China
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2026
- 252 Pages
India
From €4326EUR$4,850USD£3,719GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more